Skip to content

menu

Reed Smith LLP logo
HomeAboutSubscribeTopicsOur ServicesContact
Search
Close

Health Industry Washington Watch

Updates by Reed Smith on U.S. legislative & regulatory developments affecting the health care industry

FDA Seeks Comments on Drug Company Social Media Guidance

By Debra A. McCurdy on 20 January 2014
Print:
Email this postLike this postShare this post on LinkedIn

As reported on our Life Sciences Legal Update blog, the FDA has issued draft guidance addressing the unique challenges of drug promotion in the age of social media. Specifically, the draft guidance addresses how to submit interactive promotional media for postmarket review.  Comments on the document, “Draft Guidance for Industry on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics,” are due April 14, 2014.

Posted in Department of Health & Human Services Regulations, Food & Drug Administration Regulations, Other FDA Developments
Tags: Department of Health & Human Services, Drug Advertising, Drugs, FDA, Food & Drug Administration Developments, Other FDA Developments, social media
Related Posts
FDA LDT Rule Begins Enforcement Discretion Phaseout, But Some Discretion Remains
May 21, 2024
The Latest Episode of the LDT Drama: FDA Issues Long-Awaited Proposed Rule for Laboratory Developed Tests
October 18, 2023
FDA Issues Draft Guidance on Good Clinical Practice in Ongoing Clinical Trial Modernization Efforts
June 9, 2023

Subscribe to Health Industry Washington Watch

Updates direct to your inbox
Subscribe by Email

Links & Resources

Key Regulatory Sites

  • CMS
  • FDA
  • Federal Register
  • HHS
  • HHS OIG

Key Legislative Sites

  • Congressional Record
  • House Energy and Commerce Committee
  • House Ways and Means Committee
  • Senate Finance Committee
  • Thomas (Library of Congress)

Health Industry Washington Watch

View Our Network of Blogs
Published by
Reed Smith LLP logo
RSS Facebook LinkedIn youtube
Privacy PolicyDisclaimer

About Our Firm

At Reed Smith, everything we do is to apply our global experience in law to drive progress for our clients, for ourselves and for our communities. We are focused on outcomes, are highly collaborative and have deep industry insight. When combined with our local market knowledge and innovative mindset, this allows us to anticipate and address the needs of our clients and help them achieve their goals.

Our team of 3,000 people (including more than 1,700 lawyers) operate across 31 offices in the United States, Europe, the Middle East and Asia.

Read More...

Topics

Archives

Copyright © 2025, Reed Smith LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo